Arkansas AG’s Cease-and-Desist Letters Target Abortion Medication Providers

In a move that has sent shockwaves through the reproductive rights community, Arkansas Attorney General Tim Griffin has issued cease-and-desist letters to two healthcare providers: Choices Women’s Medical Center, Inc. (New York) and Aid Access (Netherlands).

Legal Basis for Cease-and-Desist Letters

Griffin’s letters allege that the organizations’ marketing of abortion-inducing medication violates the Arkansas Deceptive Trade Practices Act. Specifically, he claims that:

  • Abortion is illegal in Arkansas except in limited circumstances.
  • The medication pills may not be legally shipped to or used in Arkansas.

Marketing Efforts

Griffin’s investigation revealed that both organizations advertised the availability of abortion-inducing pills to Arkansans through search engine results and dedicated website pages.

Targeted Services

It’s important to note that Griffin’s cease-and-desist letters target only medication abortions performed within Arkansas state lines. This means that the organizations can continue to provide medication abortions to patients in other states.

Choices Women’s Medical Center Services

In addition to medication abortions, Choices Women’s Medical Center also offers surgical abortions in New York and travel assistance for out-of-state abortions.

Reaction from Arkansans for Limited Government

Arkansans for Limited Government, a group advocating for abortion access, has strongly condemned Griffin’s actions. In a statement, the group said:

“This is a blatant attempt to intimidate healthcare providers and prevent Arkansans from accessing essential reproductive healthcare. We will not stand idly by while the rights of women in our state are being trampled on.”

Arkansas Abortion Medication Marketing Cease-and-Desist Letters


Legal Basis for Cease-and-Desist Letters

Arkansas Attorney General Tim Griffin’s cease-and-desist letters cite the Arkansas Deceptive Trade Practices Act. Griffin contends that the organizations’ marketing of abortion-inducing medication violates the law because:

  • Abortion is illegal in Arkansas except in limited circumstances.
  • The medication pills may not be legally shipped to or used in Arkansas.

Marketing Efforts

Griffin alleges that both organizations advertised the availability of abortion-inducing pills to Arkansans through:

  • Search engine results for “abortion pills Arkansas”
  • Dedicated website pages

Targeted Services

Griffin’s cease-and-desist letters target only medication abortions performed within Arkansas state lines.


Choices Women’s Medical Center Services

In addition to medication abortions, Choices Women’s Medical Center also offers:

  • Surgical abortions in New York
  • Travel assistance for out-of-state abortions

Reaction from Arkansans for Limited Government

Arkansans for Limited Government, a group advocating for abortion access, issued a statement condemning Griffin’s actions:

“This is a blatant attempt to intimidate healthcare providers and restrict access to essential healthcare services for Arkansas women. We will not stand idly by while the rights of our citizens are trampled upon.”


Conclusion

The legality of abortion medication marketing in Arkansas remains uncertain. The cease-and-desist letters sent by Attorney General Tim Griffin are likely to face legal challenges. The outcome of these challenges will have significant implications for access to abortion care in the state.